2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
US8716486B2 · kind B2 · utility
36Cited by
21References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2009 |
| Grant date | May 6, 2014 |
| Priority date | — |
| Expiry date | Feb 24, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D213/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating or suppressing oxidative stress disorders including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-heterocyclylaminoalkyl-(p-quinone) derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.